GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $96,582,000 | +19.5% | 2,218,753 | +19.6% | 0.06% | +36.4% |
| Q1 2022 | $80,823,000 | +45.7% | 1,855,442 | +47.5% | 0.04% | +51.7% |
| Q4 2021 | $55,481,000 | +54.4% | 1,258,070 | +33.8% | 0.03% | +31.8% |
| Q3 2021 | $35,936,000 | +4.7% | 940,461 | +9.1% | 0.02% | +4.8% |
| Q2 2021 | $34,330,000 | +98.9% | 862,129 | +78.3% | 0.02% | +75.0% |
| Q1 2021 | $17,258,000 | -34.1% | 483,529 | -32.0% | 0.01% | -36.8% |
| Q4 2020 | $26,174,000 | -30.9% | 711,263 | -29.4% | 0.02% | -59.6% |
| Q3 2020 | $37,895,000 | +70.2% | 1,006,775 | +84.4% | 0.05% | +56.7% |
| Q2 2020 | $22,268,000 | -39.7% | 545,906 | -44.0% | 0.03% | -63.9% |
| Q1 2020 | $36,935,000 | +138.5% | 974,800 | +195.8% | 0.08% | +336.8% |
| Q4 2019 | $15,485,000 | +100.4% | 329,538 | +70.7% | 0.02% | +58.3% |
| Q2 2019 | $7,728,000 | -79.4% | 193,094 | -78.5% | 0.01% | -78.6% |
| Q1 2019 | $37,454,000 | +168.3% | 896,233 | +145.3% | 0.06% | +154.5% |
| Q4 2018 | $13,959,000 | +577.3% | 365,325 | +612.0% | 0.02% | +633.3% |
| Q3 2018 | $2,061,000 | -93.7% | 51,309 | -93.6% | 0.00% | -92.9% |
| Q2 2018 | $32,537,000 | +22.2% | 807,171 | +18.4% | 0.04% | +16.7% |
| Q1 2018 | $26,633,000 | -58.9% | 681,667 | -62.7% | 0.04% | -59.6% |
| Q4 2017 | $64,749,000 | +214.3% | 1,825,451 | +259.7% | 0.09% | +187.1% |
| Q3 2017 | $20,602,000 | -83.2% | 507,439 | -82.2% | 0.03% | -85.8% |
| Q2 2017 | $122,664,000 | +454.0% | 2,844,716 | +441.7% | 0.22% | +434.1% |
| Q1 2017 | $22,140,000 | -71.3% | 525,134 | -73.8% | 0.04% | -74.5% |
| Q4 2016 | $77,083,000 | +146.6% | 2,001,636 | +176.2% | 0.16% | +209.6% |
| Q3 2016 | $31,259,000 | +85.9% | 724,751 | +86.8% | 0.05% | +36.8% |
| Q2 2016 | $16,819,000 | -60.6% | 388,068 | -63.2% | 0.04% | -64.5% |
| Q1 2016 | $42,740,000 | +66.1% | 1,053,996 | +65.3% | 0.11% | +98.1% |
| Q4 2015 | $25,730,000 | +186.5% | 637,658 | +173.0% | 0.05% | +217.6% |
| Q3 2015 | $8,982,000 | -53.7% | 233,599 | -49.8% | 0.02% | -54.1% |
| Q2 2015 | $19,387,000 | +332.5% | 465,484 | +343.8% | 0.04% | +311.1% |
| Q4 2014 | $4,483,000 | -86.4% | 104,889 | -85.4% | 0.01% | -89.2% |
| Q3 2014 | $32,935,000 | +18.4% | 716,449 | +37.7% | 0.08% | +7.8% |
| Q2 2014 | $27,826,000 | +49.4% | 520,315 | +49.2% | 0.08% | +42.6% |
| Q1 2014 | $18,629,000 | +0.9% | 348,668 | +0.8% | 0.05% | -6.9% |
| Q4 2013 | $18,460,000 | -13.1% | 345,766 | -18.3% | 0.06% | -15.9% |
| Q3 2013 | $21,235,000 | – | 423,249 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |